136k views
3 votes
U.S. health care reform legislation is a high-risk area for the pharmaceutical industry. This risk belongs to which risk category?

a. Internal risk, strategic
b. External risk, compliance
c. External risk, strategic
d. Internal risk, compliance

1 Answer

0 votes

Final answer:

The risk category that the high-risk area for the pharmaceutical industry belongs to is external risk, strategic.

Step-by-step explanation:

The risk category to which the high-risk area for the pharmaceutical industry belongs is external risk, strategic.

This category refers to risks that are beyond the control of a company and emerge from external factors, such as changes in government regulations and policies.

In the case of the pharmaceutical industry, the U.S. health care reform legislation poses a risk as it can significantly impact the industry's operations, pricing, and market access.

User OganM
by
7.5k points